Mitochondrial Encephalomyopathies

Archives of Neurology

Volumn 50, Issue 11, 1993, Pages 1197-1208

  Dimauro, Salvatore ^a   Moraes, Carlos T ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE;

CITRIC ACID CYCLE; DELETION MUTANT; DISEASE CLASSIFICATION; ENCEPHALOMYOPATHY; GENE SEGREGATION; GENE TRANSLOCATION; HUMAN; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOLECULAR GENETICS; PRIORITY JOURNAL; RESPIRATORY CHAIN; REVIEW;

CHROMOSOME DELETION; CYTOCHROME-C OXIDASE DEFICIENCY; DNA; DNA REPLICATION; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MITOSIS; MULTIENZYME COMPLEXES; MUTATION; NAD(P)H DEHYDROGENASE (QUINONE); OPTIC ATROPHIES, HEREDITARY; OXIDOREDUCTASES; POINT MUTATION; SUCCINATE DEHYDROGENASE;

EID: 0027525492     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1993.00540110075008     Document Type: Article

References (84)

1. Nass S, Nass MMK. Intramitochondrial fibers with DNA characteristics. J Cell Biol. 1963;19:593-629.
2. Schatz G, Haslbrunner E, Tuppy H. Deoxyribonucleic acid associated with yeast mitochondria. Biochem Biophys Res Commun. 1964;15:127-132.
3. DiMauro S, Wallace DC, eds. Mitochondrial DNA in Human Pathology. New York, NY: Raven Press; 1993.
4. Clayton DA. Replication and transcription of vertebrate mitochondrial DNA. Annu Rev Cell Biol. 1991;7:453-478.
5. Attardi G. The human mitochondrial genetic system. In: DiMauro S, Wallace DC, eds. Mitochondrial DNA in Human Pathology. New York, NY: Raven Press; 1993:9-25.
6. Wallace DC, Lott MT. Maternally inherited diseases. In: DiMauro S, Wallace DC, eds. Mitochondrial DNA in Human Pathology. New York, NY: Raven Press; 1993:63-83.
7. Hayashi JI, Ohta S, Kikuchi A, Takemitsu M, Goto YI, Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A. 1991; 88:1371-1375.
8. Hammans SR, Sweeney MG, Holt IJ, et al. Evidence for intramitochondrial complementation between deleted and normal mitochondrial DNA in some patients with mitochondrial myopathy. J Neurol Sci. 1992;107:87-92.
9. Moraes CT, Ricci E, Petruzzella V, et al. Molecular analysis of the muscle pathology associated with mitochondrial DNA deletions. Nature Genet. 1992;1:359-367.
10. Wallace DC, Zheng X, Lott MT, et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological and biochemical characterization of a mitochondrial DNA disease. Cell. 1988;55:601-610.
11. Moraes CT, Ricci E, Arnaudo E, Bonilla E, DiMauro S, Schon EA. Quantitative defects of mitochondrial DNA. In: DiMauro S, Wallace DC, eds. Mitochondrial DNA in Human Pathology. New York, NY: Raven Press; 1993:97-108.
12. Larsson NG, Holme B, Kristiansson B. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res. 1990;28: 131-136.
13. McShane MA, Hammans SR, Sweeney M, et al. Pearson syndrome and mitochondrial encephalopathy in a patient with a deletion of mtDNA. Am J Hum Genet. 1991;48:39-42.
14. Giles RE, Blanc H, Cann RM, Wallace DC. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci U S A. 1980;77:6715-6719.
15. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem. 1992; 61:1175-1212.
16. Holt IJ, Harding AE, Morgan Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988;331:717-719.
17. Wallace DC, Singh G, Loft MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430.
18. Rowland LP, Blake D, Hirano M, et al. Clinical syndromes associated with ragged red fibers. Rev Neurol. 1991;147:467-473.
19. Poulton J, Deadman ME, Gardiner RM. Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet. 1989;1:236-240.
20. Poulton J, Deadman ME, Gardiner RM. Tandem direct duplications of mitochondrial DNA in mitochondrial myopathies: analysis of nucleotide sequence and tissue distribution. Nucleic Acids Res. 1989;17:10223-10229.
21. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med. 1989;320:1293-1299.
22. Holt IJ, Harding AE, Cooper JM, et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol. 1989;26:699-708.
23. Zeviani M, Gellera C, Pannacci M, et al. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies. Ann Neurol. 1990; 28:94-97.
24. Goto Y, Koga Y, Horai S, Nonaka I. Chronic progressive external ophthalmoplegia: a correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies. J Neurol Sci. 1990;100:63-69.
25. Degoul F, Nelson I, Lestienne P, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome and ocular myopathies: genetic, biochemical and morphological studies. J Neurol Sci. 1991;101:168-177.
26. Rotig A, Cormier V, Blanche S, et al. Pearson's marrow-pancreas syndrome: a multisystem mitochondrial disorder in infancy. J Clin Invest. 1990;86:1601-1608.
27. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol. 1992;31:391-398.
28. Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990; 348:651-653.
29. Goto YI, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta. 1991;1097:238-240.
30. Moraes CT, Ciacci F, Silvestri G, et al. Atypical clinical presentations associated with the MELAS mutation at position 2343 of human mitochondrial DNA. Neuromusc Disord. 1993;3:43-50.
31. Zeviani M, Gellera C, Antozzi C, et al. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNALeu(UUR). Lancet. 1991;338:143-147.
32. Silvestri G, Shanske SB, Whitley CBA, Schimmenti LA, Smith SA, DiMauro S. A new mtDNA mutation in the tRNA(LeuUUR) gene associated with cardiomyopathy and ragged-red fibers. Neurology. 1993;43:A402. Abstract.
33. Moraes CT, Ciacci F, Bonilla E, et al. Identification of novel pathogenic mitochondrial DNA mutations in patients with mitochondrial encephalomyopathies. Neurology. 1993;43:A401. Abstract.
34. Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell. 1990;61:931-937.
35. Silvestri G, Moraes CT, Shanske S, Oh SJ, DiMauro S. A new mtDNA mutation in the tRNALys gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet. 1992;51:1213-1217.
36. Zeviani M, Muntoni F, Savarese N, et al. A MERRF/MELAS overlap syndrome with a new point mutation in the mitochondrial DNA tRNALys gene. EurJ Hum Genet. 1993;1:80-87.
37. Silvestri G, Ciafaloni E, Santorelli F, et al. Clinical features associated with the A→G transition at nucleotide 8344 of mtDNA ('MERRF' mutation). Neurology. 1993;43:1200-1206.
38. Holt IJ, Harding AE, Petty RK, Morgan Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet. 1990; 46:428-433.
39. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet. 1992;50:852-858.
40. Shoffner JM, Fernhoff PM, Krawiecki NS, et al. Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology. 1992;42:2168-2174.
41. Sakuta R, Goto Y, Horai S, et al. Mitochondrial DNA mutation and Leigh's syndrome. Ann Neurol. 1992;32:597-598.
42. Harding AE, Holt IJ, Sweeney MG, Brockington M, Davis MB. Prenatal diagnosis of mitochondrial DNA 8993 T→G disease. Am J Hum Genet. 1992;50: 629-633.
43. Ciafaloni E, Santorelli F, Shanske S, et al. Maternally inherited Leigh syndrome. J Pediatr. 1993;122:419-422.
44. Santorelli F, Shanske S, Macaya A, DeVivo DC, DiMauro S. The mutation at nt8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol. In press.
45. Newman NJ. Leber's hereditary optic neuropathy. Ophthalmol Clin North Am. 1991;4:431-447.
46. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430.
47. Vilkki J, Ott J, Savontaus ML, Aula P, Nikoskelainen EK. Optic atrophy in Leber hereditary optic neuroretinopathy is probably determined by an X-chromosomal gene closely linked to DXS7. Am J Hum Genet. 1991;48:486-491.
48. Bonilla E, Sciacco M, Tanji K, Sparaco M, Petruzzella V, Moraes CT. New morphological approaches to the study of mitochondrial encephalomyopathies. Brain Pathol. 1992;2:113-119.
49. King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science. 1989;246:500-503.
50. Moraes CT, Ricci E, Bonilla E, DiMauro S, Schon EA. The mitochondrial tRNALeu(UUR) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet. 1992;50:934-949.
51. Mita S, Schmidt B, Schon EA, DiMauro S, Bonilla E. Detection of 'deleted' mitochondrial genomes in cytochrome-c-oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc Natl Acad Sci USA. 1989;86:9509-9513.
52. Nakase H, Moraes CT, Rizzuto R, Lombes A, DiMauro S, Schon EA. Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis. Am J Hum Genet. 1990;46:418-427.
53. Chomyn A, Meola G, Bresolin N, Lai ST, Scarlato G, Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol. 1991;11: 2236-2244.
54. King MP, Koga Y, Davidson M, Schon EA. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNALeu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Mol Cell Biol. 1992;12:480-490.
55. Yoneda M, Chomyn A, Martinuzzi A, Hurko O, Attardi G. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proc Natl Acad Sci U S A. 1992;89:11164-11168.
56. Parker WD, Oley CA, Parks JK. A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy. N Engl J Med. 1989;320:1331-1333.
57. Larsson NG, Anderson O, Holme E, Oldfors A, Wahlstrom J. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol. 1991;30: 701-708.
58. Bodnar AG, Cooper JM, Holt IJ, Leonard JV, Schapira AHV. Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion. Am J Hum Genet. 1993;53:663-669.
59. Morgan-Hughes JA. Mitochondrial diseases. In: Mastaglia FL, Walton JN, eds. Skeletal Muscle Pathology. 2nd ed. New York, NY: Churchill Livingstone; 1992: 367-424.
60. DiMauro S. Mitochondrial encephalamyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Kunkel LM, eds. The Metabolic and Genetic Basis of Neurological Disease. Boston, Mass: Butterworth-Heinemann; 1993:665-694.
61. Dahl HHM, Brown GK, Brown RM, et al. Mutations and polymorphisms in the pyruvate dehydrogenase El alpha gene. Hum Mutat. 1992;1:97-102.
62. Jackson S, Turnbull DM. Lipid disorders of muscle. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Kunkel LM, eds. The Molecular and Genetic Basis of Neurological Disease. Boston, Mass: Butterworth-Heinemann; 1993:651-661.
63. Taroni F, Verderio E, Fiorucci S, et al. Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci U S A. 1992; 89:8429-8433.
64. Miranda AF, Ishii S, DiMauro S, Shay JW. Cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence for a nuclear DNA-encoded mutation. Neurology. 1989;39:697-702.
65. Morgan-Hughes JA, Schapira AHV, Cooper JM, Clark JB. Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases. J Bioenerg Biomembr 1986;20:365-382.
66. Watmough NJ, Birch-Machin MA, Bindoff LA, et al. Tissue-specific defect of complex I of the mitochondrial respiratory chain. Biochem Biophys Res Commun. 1989;160:623-627.
67. Ogasahara S, Engel AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A. 1989; 86:2379-2382.
68. Kennaway NG. Defects in the cytochrome bcl complex in mitochondrial diseases. J Bioenerg Biomembr. 1988;20:325-352.
69. Darley Usmar VM, Watanabe M, Uchiyama Y, et al. Mitochondrial myopathy: tissue-specific expression of a defect in ubiquinol-cytochrome c reductase. Clin Chim Acta. 1986;158:253-261.
70. Eleff S, Kennaway NG, Buist NR, et al. 31P-NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci U S A. 1984;81:3529-3533.
71. Papadimitriou A, Neustein HB, DiMauro S, Stanton R, Bresolin N. Histiocytoid cardiomyopathy of infancy: deficiency of reducible cytochrome b in heart mitochondria. Pediatr Res. 1984;18:1023-1028.
72. DiMauro S, Lombes A, Nakase H, et al. Cytochrome c oxidase deficiency. Pediatr Res. 1990;28:536-541.
73. Tritschler HJ, Bonilla E, Lombes A, et al. Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology. 1991;41:300-305.
74. Bardosi A, Creutzfeldt W, DiMauro S, et al. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase: a new mitochondrial multisystem disorder. Acta Neuropathol (Berl). 1987;74:248-258.
75. Hirano M, Silvestri G, Blake D, et al. Mitochondrial neuro-gastrointestinal encephalomyopathy (MNGIE): clinical, biochemical and genetic features of an autosomal recessive mitochondrial disorder. Neurology. In press.
76. Schatz G. The mitochondrial protein import machinery. In: Sato T, DiMauro S, eds. Mitochondrial Encephalomyopathies. New York, NY: Raven Press; 1991: 57-73.
77. Ledley FD, Jansen R, Nham SU, Fenton WA, Rosenberg LE. Mutation eliminating mitochondrial leader sequence of methylmalonyl-CoA mutase causes mutO methylmalonic acidemia. Proc Natl Acad Sci U S A. 1990;87:3147-3150.
78. Schapira AHV, Cooper JM, Morgan Hughes JA, Landon DN, Clark JB. Mitochondrial myopathy with a defect of mitochondrial protein transport. N Engl J Med. 1990;323:37-42.
79. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature. 1989;339:309-311.
80. Zeviani M, Tiranti V. Inherited mendelian defects. In: DiMauro S, Wallace DC, eds. Mitochondrial DNA in Human Pathology. New York, NY: Raven Press; 1993:85-95.
81. Moraes CT, Shanske S, Tritschler HJ, et al. MtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet. 1991;48:492-501.
82. Tritschler HJ, Andreetta F, Moraes CT, et al. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology. 1992;42: 209-217.
83. van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W, et al. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet. 1992;1:368-371.
84. Tanike M, Fukushima H, Yanagihara I, et al. Mitochondrial tRNAlle mutation in fatal cardiomyopathy. Biochem Biophys Res Commun. 1992;186:47-53.